Sera Prognostics: Initiating With Hold, Potential Of PreTRM Test, But Uncertain Commercial Timeline

Stock Information for Sera Prognostics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Sera Prognostics Inc.

Sera Announces Publication Acceptance for PRIME Study
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth
SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2025 FINANCIAL RESULTS ON NOVEMBER 13, 2025
Sera Prognostics Names Dr. Tiffany Inglis Chief Medical Officer
SERA PROGNOSTICS TO PRESENT AT H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCE
SERA PROGNOSTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2025 Financial Results on August 6, 2025

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.